e.g. Tata motors, Reliance MF, 500570

Orchid Pharma Ltd. - Research Center

524372 ORCHPHARMA Group (B) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21
Income
Operating income 921.93 819.37 665.90 556.97 450.70
Expenses
Material consumed 563.61 498.39 397.18 326.80 240.76
Manufacturing expenses 64.98 62.92 61.26 52.74 39.31
Personnel expenses 86.36 69.64 65.35 60.21 64.40
Selling expenses 0.03 0.03 0.04 0.04 0.02
Adminstrative expenses 83.41 77.70 58.45 59.93 48.31
Expenses capitalised - - - - -
Cost of sales 798.40 708.69 582.28 499.72 392.81
Operating profit 123.53 110.68 83.62 57.26 57.89
Other recurring income 31.93 30.39 19.43 9.00 6.48
Adjusted PBDIT 155.46 141.07 103.05 66.26 64.36
Financial expenses 14.54 16.33 32.23 87.02 51.34
Depreciation 34.44 33.22 54.79 32.01 108.90
Other write offs - - - - -
Adjusted PBT 106.48 91.52 16.04 -52.77 -95.87
Tax charges - -3.23 - - -
Adjusted PAT - 94.75 - - -
Non recurring items - - 38.15 47.96 -21.28
Other non cash adjustments - - - - -
Reported net profit 106.48 94.75 54.19 -4.81 -117.15
Earnigs before appropriation -1,881.90 -1,987.93 -2,082.45 -2,138.10 -2,133.89
Equity dividend - - - - -
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings -1,881.90 -1,987.93 -2,082.45 -2,138.10 -2,133.89
Close
Add Orchid Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Orchid Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback